Brokerages Set DENTSPLY SIRONA Inc. (XRAY) Target Price at $67.09

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given an average rating of “Hold” by the fifteen brokerages that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $66.00.

XRAY has been the topic of a number of analyst reports. Zacks Investment Research raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research report on Thursday, July 13th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $66.00 price target (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th.

Several large investors have recently modified their holdings of the company. Commonwealth Bank of Australia raised its stake in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 260 shares during the period. Acrospire Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter valued at $113,000. Dupont Capital Management Corp acquired a new stake in shares of DENTSPLY SIRONA during the second quarter valued at $116,000. Korea Investment CORP raised its stake in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after buying an additional 1,251 shares during the period. Finally, Sphera Funds Management LTD. acquired a new stake in shares of DENTSPLY SIRONA during the second quarter valued at $162,000. 95.13% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA (XRAY) traded up 0.09% during mid-day trading on Friday, hitting $53.53. The company had a trading volume of 707,534 shares. The company has a 50-day moving average price of $62.03 and a 200 day moving average price of $62.28. The company’s market capitalization is $12.29 billion. DENTSPLY SIRONA has a 52-week low of $52.73 and a 52-week high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.65. The company had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.76 EPS. On average, analysts forecast that DENTSPLY SIRONA will post $2.72 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set DENTSPLY SIRONA Inc. (XRAY) Target Price at $67.09” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://sportsperspectives.com/2017/08/17/brokerages-set-dentsply-sirona-inc-xray-target-price-at-67-09.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply